Loading stock data…
NAGE
$4.85+0.12 (+2.54%)
Market ClosedLast close May 1
Niagen Bioscience, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Niagen Bioscience, Inc. in the Healthcare sector is trading at $4.85. The stock is currently near its 52-week low of $4.16, remaining 30.3% below its 200-day moving average. Technical signals show neutral RSI of 58 and bullish MACD crossover, explaining why NAGE maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 58) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$4.85
Potential Downside
9.8%
Whystock Fair Value$4.37
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Mean target$13.60+180.4%
Range$12.00 – $18.00
Fundamentals
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that con...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$402.00M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
25.10
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.23
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.17%
Volume
Today's trading volume
404,159
Recent News
Payoneer Global And 2 Exciting Penny Stocks To Watch
In the last week, the market has stayed flat, but over the past 12 months, it has risen by 29%, with earnings forecasted to grow annually by 16%. While penny stocks might seem like a term from a bygone era, they still hold significant potential for investors looking to explore smaller or newer companies that boast strong financials. This article highlights three such penny stocks that could offer both affordability and growth opportunities in today's market landscape.
AbCellera Biologics Among 3 Promising Penny Stocks
In the last week, the market has stayed flat, but over the past 12 months, it has risen by 29%, with earnings forecast to grow by 16% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when built on solid financials. In this article, we explore three penny stocks that combine balance sheet strength with potential for outsized gains, providing investors a chance to discover hidden...
FatPipe Leads The Charge With These 3 Penny Stock Contenders
The United States market remained flat over the last week, but it has seen a significant 28% increase over the past year with earnings expected to grow by 16% annually. In light of these conditions, identifying stocks with strong fundamentals becomes crucial, especially within the realm of penny stocks—a term that may seem outdated but still holds relevance for investors seeking growth opportunities at lower price points. This article explores three penny stock contenders that demonstrate...
Fuel Tech Leads The Pack Of 3 Noteworthy Penny Stocks
In the last week, the market has stayed flat, but it is up 29% over the past year with earnings expected to grow by 16% per annum over the next few years. In this context, identifying stocks that combine value and growth potential becomes crucial for investors looking to capitalize on these trends. While penny stocks might seem like a relic from earlier market days, they remain relevant due to their affordability and potential for growth when backed by strong financials. Here, we explore...
3 Promising Penny Stocks With Market Caps Below $300M
Over the last 7 days, the United States market has remained flat, but it is up 29% over the past year with earnings forecasted to grow by 16% annually. For investors willing to explore beyond well-known companies, penny stocks—typically smaller or newer firms—can offer intriguing opportunities. Despite being an outdated term, penny stocks still represent a viable investment area, especially when focusing on those with strong financials and growth potential.